SSL plans to sell medical division

Durex-to-Scholl firm SSL International today pledged to sell its medical division and use the proceeds to reduce debt and boost the consumer arm.

The company has been conducting a strategic review in an effort to improve shareholder value after a torrid period which has seen the group’s medical division struggle to match the performance of its consumer brands.